Randomized Controlled Phase 2 Study to Evaluate Iptacopan in Participants with Active ANCA-Associated Vasculitis (AAV): Interim Renal-Focused Results (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-OR077; Pres time: Oct 24, 2026; 05:18 PM - 05:30 PM; Location: Four Seasons Ballroom 2; "Abstract and presentation is embargoed for release at date and time of presentation."
Clinical • Late-breaking abstract • P2 data • ANCA Vasculitis • Vasculitis
|
|
Grégory Pugnet1; Rodolfo Nicolas Alvarado11; Adrian Schreiber8; Anna Bazsó15; Albrecht Betrains12; Shilpa Muthusamy16; Malika Hanser9; Julia Wagner9; Swati Ghanshani10; Prasanna Kumar Nidamarthy10; Imelda Schuhmann9; Benjamin Terrier2; Guido Junge9; Christian Löffler3; Zhanzheng Zhao13; Sebastian Juan Magri14; Jorge Alejandro Brigante4; Fatma Alibaz-Oner5; Rachel B. Jones6; Min Chen7
|